AI filing briefs · archive

8-K filings in October 2024, explained

590 material Form 8-K filings that 521 companies we cover made with the SEC in October 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

1 of 590 briefs matches

newest first · times in ET

CVSCVS HEALTH Corp Oct 18, 6:46 AM ET

CVS Health replaces CEO Karen Lynch with David Joyner; Q3 adjusted EPS $1.05 to $1.10

Negative leadership Written later 2.02 5.02 7.01

CVS Health appointed David Joyner as President and Chief Executive Officer effective October 17, 2024, replacing Karen Lynch, who also left the Board, and named Roger Farah Executive Chairman. The company also gave preliminary third quarter 2024 guidance of $0.03 to $0.08 GAAP diluted EPS and $1.05 to $1.10 Adjusted EPS, citing about $1.1 billion in premium deficiency reserve charges and about $1.2 billion in restructuring charges, and told investors not to rely on its prior guidance from August 7, 2024.

David Joyner, previously executive vice president and president of Pharmacy Services, became CEO effective October 17, 2024; Roger Farah is Executive Chairman.
Preliminary Q3 2024 GAAP diluted EPS of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10.
Premium deficiency reserve charges of about $1.1 billion lowered Q3 Adjusted EPS by $0.63; medical benefit ratio expected at about 95.2%.
Karen Lynch will provide advisory services for six months at a $375,000 monthly fee; her non-compete extends to 30 months. Q3 earnings call is scheduled for November 6, 2024.

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.